Received: 29 June 2022
Accepted: 26 October 2022
First Online: 26 November 2022
: Ethical approval for this study was waived by the Institutional Review Board of the managing institution, Johns Hopkins University.
: Verbal consent was obtained from all patients.
: Dr. AA has received funding from the Gilead (scientific advisory board, site PI for multi-site study) and Merck (scientific advisory board, consultant, site PI for multi-site study) within the past 3 years.